Cargando…

Impact of age and vector construct on striatal and nigral transgene expression

Therapeutic protein delivery using viral vectors has shown promise in preclinical models of Parkinson’s disease (PD) but clinical trial success remains elusive. This may partially be due to a failure to include advanced age as a covariate despite aging being the primary risk factor for PD. We invest...

Descripción completa

Detalles Bibliográficos
Autores principales:	Polinski, Nicole K, Manfredsson, Fredric P, Benskey, Matthew J, Fischer, D Luke, Kemp, Christopher J, Steece-Collier, Kathy, Sandoval, Ivette M, Paumier, Katrina L, Sortwell, Caryl E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5142515/ https://www.ncbi.nlm.nih.gov/pubmed/27933309 http://dx.doi.org/10.1038/mtm.2016.82

Ejemplares similares

Silencing Alpha Synuclein in Mature Nigral Neurons Results in Rapid Neuroinflammation and Subsequent Toxicity
por: Benskey, Matthew J., et al.
Publicado: (2018)

Genetic silencing of striatal CaV1.3 prevents and ameliorates levodopa dyskinesia
por: Steece‐Collier, Kathy, et al.
Publicado: (2019)

Downregulation of striatal Ca(V)1.3 inhibits the escalation of levodopa-induced dyskinesia in male and female parkinsonian rats of advanced age
por: Caulfield, Margaret E., et al.
Publicado: (2023)

High-Frequency Stimulation of the Rat Entopeduncular Nucleus Does Not Provide Functional or Morphological Neuroprotection from 6-Hydroxydopamine
por: Fischer, D. Luke, et al.
Publicado: (2015)

The BDNF Val66Met polymorphism (rs6265) enhances dopamine neuron graft efficacy and side-effect liability in rs6265 knock-in rats
por: Mercado, Natosha M., et al.
Publicado: (2020)

Subthalamic Nucleus Deep Brain Stimulation Does Not Modify the Functional Deficits or Axonopathy Induced by Nigrostriatal α-Synuclein Overexpression
por: Fischer, D. Luke, et al.
Publicado: (2017)

Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration
por: Duffy, Megan F., et al.
Publicado: (2018)

Regulation of dopamine neurotransmission from serotonergic neurons by ectopic expression of the dopamine D2 autoreceptor blocks levodopa-induced dyskinesia
por: Sellnow, Rhyomi C., et al.
Publicado: (2019)

Correction to: Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration
por: Duffy, Megan F., et al.
Publicado: (2018)

Cell therapy for Parkinson's disease: Why it doesn't work every time
por: Collier, Timothy J., et al.
Publicado: (2019)

The Longitudinal Transcriptomic Response of the Substantia Nigra to Intrastriatal 6-Hydroxydopamine Reveals Significant Upregulation of Regeneration-Associated Genes
por: Kanaan, Nicholas M., et al.
Publicado: (2015)

Striatal Afferent BDNF Is Disrupted by Synucleinopathy and Partially Restored by STN DBS
por: Miller, Kathryn M., et al.
Publicado: (2021)

Is Alpha-Synuclein Loss-of-Function a Contributor to Parkinsonian Pathology? Evidence from Non-human Primates
por: Collier, Timothy J., et al.
Publicado: (2016)

The contribution of alpha synuclein to neuronal survival and function – Implications for Parkinson's disease
por: Benskey, Matthew J., et al.
Publicado: (2016)

BDNF rs10501087, rs1491850 and rs11030094 polymorphisms associated with delayed progression in early-stage Parkinson's disease
por: Fischer, D. Luke, et al.
Publicado: (2022)

α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson’s disease
por: Cole, Tracy A., et al.
Publicado: (2021)

Gene Therapy to Modulate Alpha-Synuclein in Synucleinopathies
por: Sandoval, Ivette M., et al.
Publicado: (2021)

BDNF provides many routes toward STN DBS‐mediated disease modification
por: Fischer, D. Luke, et al.
Publicado: (2018)

Reward expectation enhances action-related activity of nigral dopaminergic and two striatal output pathways
por: Rios, Alain, et al.
Publicado: (2023)

Microglial depletion does not impact alpha-synuclein aggregation or nigrostriatal degeneration in the rat preformed fibril model
por: Stoll, Anna C., et al.
Publicado: (2023)

Quality Over Quantity: Advantages of Using Alpha-Synuclein Preformed Fibril Triggered Synucleinopathy to Model Idiopathic Parkinson’s Disease
por: Duffy, Megan F., et al.
Publicado: (2018)

A comparison of machine learning approaches for the quantification of microglial cells in the brain of mice, rats and non-human primates
por: Anwer, Danish M., et al.
Publicado: (2023)

Morphological and Behavioral Impact of AAV2/5-Mediated Overexpression of Human Wildtype Alpha-Synuclein in the Rat Nigrostriatal System
por: Gombash, Sara E., et al.
Publicado: (2013)

Rationally Engineered AAV Capsids Improve Transduction and Volumetric Spread in the CNS
por: Kanaan, Nicholas M., et al.
Publicado: (2017)

The Future of GDNF in Parkinson's Disease
por: Manfredsson, Fredric P., et al.
Publicado: (2020)

Repairing the Aged Parkinsonian Striatum: Lessons from the Lab and Clinic
por: Mercado, Natosha M, et al.
Publicado: (2016)

Targeted Gene Delivery to the Enteric Nervous System Using AAV: A Comparison Across Serotypes and Capsid Mutants
por: Benskey, Matthew J, et al.
Publicado: (2015)

New Frontiers in Neurodegeneration and Regeneration Associated with Brain-Derived Neurotrophic Factor and the rs6265 Single Nucleotide Polymorphism
por: Szarowicz, Carlye A., et al.
Publicado: (2022)

Activation of GSK-3β and Caspase-3 Occurs in Nigral Dopamine Neurons during the Development of Apoptosis Activated by a Striatal Injection of 6-Hydroxydopamine
por: Hernandez-Baltazar, Daniel, et al.
Publicado: (2013)

Chondroitinase ABC reduces dopaminergic nigral cell death and striatal terminal loss in a 6-hydroxydopamine partial lesion mouse model of Parkinson’s disease
por: Fletcher, Edward J. R., et al.
Publicado: (2019)

Nigral iron deposition in common tremor disorders
por: Homayoon, Nina, et al.
Publicado: (2018)

Discovery of nigral dopaminergic neurogenesis in adult mice
por: Morrison, Brad E.
Publicado: (2016)

Height and nigral neuron density in Parkinson’s disease
por: Saari, Laura, et al.
Publicado: (2022)

Behavioral and Biochemical Assessment of Monoaminergic Neural Transplants to Rat Frontal Neocortex
por: Sortwell, Caryl E., et al.
Publicado: (1992)

A comparison of AAV-vector production methods for gene therapy and preclinical assessment
por: Davidsson, Marcus, et al.
Publicado: (2020)

Deficiency in BDNF/TrkB Neurotrophic Activity Stimulates δ-Secretase by Upregulating C/EBPβ in Alzheimer’s Disease
por: Wang, Zhi-Hao, et al.
Publicado: (2019)

Phosphodiesterase 9A Inhibition Facilitates Corticostriatal Transmission in Wild-Type and Transgenic Rats That Model Huntington’s Disease
por: Chakroborty, Shreaya, et al.
Publicado: (2020)

Beta2-adrenoreceptor agonist clenbuterol produces transient decreases in alpha-synuclein mRNA but no long-term reduction in protein
por: Patterson, Joseph R., et al.
Publicado: (2022)

Netrin-1 receptor UNC5C cleavage by active δ-secretase enhances neurodegeneration, promoting Alzheimer’s disease pathologies
por: Chen, Guiqin, et al.
Publicado: (2021)

Human decisions about when to act originate within a basal forebrain–nigral circuit
por: Khalighinejad, Nima, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4oaoau3pidlvani4bvi97uljqk